Method of using punicic acid to enhance immune response and prevent metabolic disorders
US8822543B2 · kind B2 · utility
1Cited by
6References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 10, 2012 |
| Grant date | Sep 2, 2014 |
| Priority date | — |
| Expiry date | Feb 10, 2032 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a method of enhancing the immune response of an animal, including mammals and humans, to prevent or ameliorate immunoinflammatory diseases such as Inflammatory Bowel Disease, increase immune system development, maintain or increase CD4+ and CD8+ T lymphocyte levels, increase immune function, increase immune response against viruses and prevent or ameliorate the Metabolic Syndrome, Type 2 diabetes and obesity by administering orally or parenterally a therapeutically effective amount of punicic acid to the animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.